SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $482,000 | -16.5% | 67,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $577,000 | +31.7% | 67,000 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $438,000 | -71.3% | 65,000 | 0.0% | 0.00% | -75.0% |
| Q2 2021 | $1,527,000 | +22.7% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,245,000 | +1224.5% | 65,000 | +99.4% | 0.00% | – |
| Q2 2019 | $94,000 | -44.0% | 32,600 | +64.6% | 0.00% | -100.0% |
| Q1 2019 | $168,000 | +124.0% | 19,800 | +21.5% | 0.00% | – |
| Q4 2018 | $75,000 | -55.4% | 16,300 | -17.7% | 0.00% | -100.0% |
| Q3 2018 | $168,000 | -7.7% | 19,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $182,000 | +23.8% | 19,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $147,000 | -46.4% | 19,800 | -2.5% | 0.00% | -50.0% |
| Q4 2017 | $274,000 | 0.0% | 20,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $274,000 | +16.1% | 20,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $236,000 | -61.1% | 20,300 | 0.0% | 0.00% | -71.4% |
| Q2 2016 | $606,000 | +43.6% | 20,300 | +20.8% | 0.01% | +40.0% |
| Q1 2016 | $422,000 | – | 16,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |